Skip to content

Antibody Titration to Detect Anti-Cardiolipin Antibodies (IgG)

Published: August 9, 2026Updated: August 16, 2026

This test measures the level of antibodies in your blood that may be linked to certain autoimmune conditions or blood clotting disorders. It helps assess potential risks for conditions like lupus or antiphospholipid syndrome.

Quick summary

["This test helps identify possible autoimmune or clotting-related conditions by detecting specific antibodies in your blood."]

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
5241-5
Short code
LCMV Ab Titr Ser CF
Synonyms
LCMV Ab Titr Ser CF
Category
chemistry
Sample
serum
Container
Red-top tube (SST)
Units
N/A
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
Method
comp-fix
Specimen volume
5 mL
Stability
Room temperature: 4h, Refrigerated: 24h, Frozen: 7d
Hemolysis max
500
Lipemia max
1000
Icterus max
500
TAT
4–24 hours
Order
routine

Why This Test Might Be Ordered

Your healthcare provider may recommend this test if you have symptoms like unexplained fatigue, joint pain, or a history of blood clots. It may also be used to monitor conditions such as lupus or other autoimmune diseases where antibody activity is suspected.

What to Expect Before the Test

No special preparation is needed for this blood test. You may have a small needle inserted into your arm to draw blood, which usually takes a few minutes. If you’re on blood thinners, let your provider know before the test.

What the Results Mean

Results are qualitative (positive or negative) and indicate whether your body has produced these antibodies. Elevated levels may suggest an autoimmune response or increased risk of clotting, but results alone don’t diagnose a condition.

Common Conditions Linked to Positive Results

Positive results may be associated with autoimmune diseases like lupus, antiphospholipid syndrome, or other connective tissue disorders. They can also appear in people without symptoms, so further testing may be needed for diagnosis.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

This test helps identify the presence of anti-cardiolipin antibodies, which are linked to autoimmune conditions and blood clotting disorders. While elevated levels may raise concern, they often require additional evaluation to determine the cause and guide treatment.

Short name

Anti-Cardiolipin Antibody Screening (IgG)

Frequently asked questions

What does a positive result mean for my health?
A positive result means your blood contains antibodies against cardiolipin, which may indicate an autoimmune response or increased risk of clotting. This doesn’t diagnose a specific condition but may prompt further testing or monitoring.
Do I need to fast before this test?
No fasting is required for this blood test. However, inform your provider if you’re on blood thinners or have any other health conditions that might affect results.
How long will it take to get my results?
Results are typically available within a few days to a week, depending on your lab. Follow-up with your healthcare provider to discuss the meaning of your results.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy